Medical Oncology Practice Valuation – Art & Science

Medical Oncology Practice Valuation – Art & Science

Medical Oncology Practice Valuation Art and Science The Oncology Valuation Series November 27, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc. “In the short run, the market is a voting machine but in the long run, it is a .”                                                                                         Benjamin Graham I was [...]

Read more
EBITDA – The Oncology Valuation Series

EBITDA – The Oncology Valuation Series

  EBITDA What is it, and why does it matter? The Oncology Valuation Series November 21, 2018 Wes Chapman President & CEO of Verdi Oncology, Inc.   My job puts me in front of physician owners of medical oncology practices at least 4-5 times per month, and invariably [...]

Read more